Axillary lymph node (ALN) metastasis is a critical factor influencing prognosis and treatment strategies in breast cancer patients. However, traditional methods—ranging from physical examination to ultrasound—often lack the precision required for clinical decision-making. In recent years, ultrasound radiomics and deep learning have emerged as promising solutions, leveraging high-throughput quantitative features from ultrasound images to enhance detection accuracy. This review explores the development and application of radiomics and deep learning across multiple ultrasound modalities (grayscale, elastography, and contrast-enhanced ultrasound), as well as in multimodal imaging approaches that integrate ultrasound with MRI and PET/CT, underscoring the benefits of incorporating clinicopathological variables to boost predictive performance. These studies provide a vital foundation for personalized treatment and precision medicine in breast cancer management.

Intestinal stricture is a severe complication of Crohn's disease (CD), and the accurate differentiation of fibrotic strictures holds significant clinical value for guiding therapeutic decision-making. Due to the frequent difficulty in endoscopic passage caused by luminal narrowing, the assessment of lesions and tissue biopsy are often limited. In contrast, cross-sectional imaging techniques not only provide a comprehensive evaluation of intestinal lesions but also reveal extraintestinal changes, offering critical evidence for clinical decisions. With the rapid advancement of imaging technology, various novel radiological methods have emerged, providing new approaches for the assessment of intestinal fibrosis in CD strictures. Through a literature review, this article summarizes the latest research progress in advanced imaging techniques, including ultrasound elastography, magnetic resonance imaging(MRI) diffusion-weighted imaging, magnetization transfer MRI, and fibroblast activation protein inhibitor (FAPI)- positron emission computed tomography(PET). Additionally, it explores the potential applications and future directions of artificial intelligence and radiomics in the detection and grading of CD-associated fibrosis.

Crohn's disease (CD) is a chronic inflammatory bowel disease with complicated pathogenesis and prolonged condition. In recent years, with the development of targeted therapy, biological agents have been widely used in the treatment of CD, which has significantly improved the prognosis of CD patients. If the efficacy evaluation can be carried out at the early stage of targeted therapy, it may help to figure out the patients who can benefit from the treatment and optimize the treatment plan for the ineffective patients in time. In the evaluation of CD activity and efficacy, ultrasound has the advantages of high accuracy, no radiation and high patient acceptance, and therefore has potential clinical application value in the early efficacy evaluation of CD targeted therapy. This article reviews the research progress to provides a reference for optimizing the treatment plan for CD patients.

Crohn's disease(CD)is a kind of inflammatory bowel disease, and its incidence rate is increasing year by year. Mesenteric creeping fat, a special sign of CD closely related to its intestinal inflammation and stenosis, has become a research hotspot in recent years. The formation mechanism of mesenteric creeping fat may be related to the migration of adipocytes and the translocation of intestinal microbiota. MRI, CT and US are commonly used imaging evaluation methods for CD, which can show the sign of creeping fat and evaluate the inflammation of intestinal wall and intestinal stenosis. However, the relationship between mesenteric creeping fat and inflammatory activity, stenosis and prognosis of CD needs to be further studied. The purpose of this review is to introduce the pathogenesis and clinical significance of mesenteric creeping fat, as well as the evaluation indicators of different imaging methods, and to further explore the relationship between mesenteric creeping fat and CD inflammatory activity and stenosis.